Form 4: Core Scientific Director Elizabeth Crain Receives Restricted Stock Unit Grant

Sentiment:

Insider Transaction Report


Core Scientific, Inc. Director Elizabeth Crain was granted 46,773 restricted stock units (RSUs) as part of her compensation, vesting in full on May 14, 2028.

Summary

  • Elizabeth Crain, a Director of Core Scientific, Inc. (CORZ), acquired 46,773 shares of Common Stock in the form of Restricted Stock Units (RSUs).
  • The transaction occurred on May 29, 2025, with an acquisition price of $0 per RSU, indicating a grant.
  • These RSUs are scheduled to vest in full on May 14, 2028, contingent upon Ms. Crain's continued service to Core Scientific as a non-employee director.
  • Following this transaction, Ms. Crain beneficially owns 46,773 shares directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the RSU grant aligns the director's interests with shareholders, which is a good governance practice, and it's a routine compensation event.

Positives

  • The grant of Restricted Stock Units (RSUs) to a director aligns their interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
  • This form of compensation is a common practice for non-employee directors, indicating standard corporate governance and compensation policies.

Future Outlook

The future outlook for the granted RSUs is tied to the director's continued service and the company's stock performance until the full vesting date of May 14, 2028.

Industry Context

The granting of restricted stock units to non-employee directors is a standard compensation practice across various industries, particularly in publicly traded companies, to attract and retain qualified board members and align their long-term interests with shareholder value.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a component of non-employee director compensation is a widely adopted practice across public companies, including those in the technology and cryptocurrency mining sectors, such as Marathon Digital Holdings (MARA) or Riot Platforms (RIOT), which also utilize equity-based incentives for their board members.
  • The vesting schedule, contingent on continued service, is typical for such grants, ensuring long-term commitment from board members.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Policy ImplementationGrant of 46,773 Restricted Stock Units (RSUs) to non-employee director Elizabeth Crain as part of her compensation package.05/29/2025Aligns director's long-term interests with shareholder value and is a standard practice for attracting and retaining qualified board members.

Related Party Transactions

  • The RSU grant to Elizabeth Crain, a director, constitutes a related party transaction, which is a standard and disclosed form of compensation for board members.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the director's financial interests with the company's long-term performance, potentially benefiting shareholders through improved governance and strategic decisions.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • Continued service of Elizabeth Crain as a non-employee director until May 14, 2028, for the RSUs to vest.

Key Dates

DateDescription
05/29/2025Date of RSU grant transaction for Elizabeth Crain.
05/14/2028Full vesting date for the 46,773 RSUs granted to Elizabeth Crain, contingent on continued service.

Keywords

Core Scientific, CORZ, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.